Results 191 to 200 of about 85,740 (261)

MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures. [PDF]

J Virol
Chiok KL, Jenik K, Fenton M, Falzarano D, Dhar N, Banerjee A.   +5 more
europepmc   +1 more source

MERS-CoV encodes another suppressor of innate antiviral responses.

, 2016
Rabouw Huib H., A. Langereis Martijn, Knaap Robert C. M., Dalebout Tim J., Javier Cantón, Sola Isabel, Luis Enjuanes, Jörg Peter, Marjolein Kikkert, J. de Groot Raoul, J. M. van Kuppeveld Frank   +10 more
openalex   +2 more sources

Yeni Coronavirus Salgını: MERS-CoV

Türkiye Halk Sağlığı Dergisi, 2014
Muhsin Akbaba, Burak Kurt, Ersin Nazlıcan   +2 more
openaire   +2 more sources

Mapping Potential Amplification and Transmission Hotspots for MERS-CoV, Kenya [PDF]

, 2018
Stephen Gikonyo, Tabitha Kimani, Joseph Matere, Joshua Kimutai, Stella Kiambi, Austine O. Bitek, Kisa-Juma Ngeiywa, Yilma J. Makonnen, Astrid Tripodi, Subhash Morzaria, Juan Lubroth, Gabriel Rugalema, Folorunso O. Fasina   +12 more
openalex   +1 more source

MERS-CoV in Africa—an enigma with relevance to COVID-19 [PDF]

, 2020
Stanley Perlman, Alimuddin Zumla
openalex   +1 more source

Lessons Learned From the MERS-CoV Outbreak

Cardiovascular Revascularization Medicine, 2021
Sutton, Nadia R., Kawamoto, Kris R.
openaire   +2 more sources

MERS-CoV remains a persistent threat amid global events

Jaffar A. Al‐Tawfiq, Sameera Al Johani, Ziad A. Memish   +2 more
openalex   +1 more source

Cross-neutralization ability of anti-MERS-CoV monoclonal antibodies against a variety of merbecoviruses. [PDF]

Front Microbiol
Pan L, Kaku Y, Tolentino JE, Kosugi Y, Sato K.   +4 more
europepmc   +1 more source

Remdesivir as a possible therapeutic option for the COVID-19 [PDF]

, 2020
Al-Homoud, Ali H., Al-Tawfiq, Jaffar A., Memish, Ziad A.   +2 more
core   +1 more source

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir

, 2016
Hamzah A. Mohd, Jaffar A. Al‐Tawfiq, Ziad A. Memish   +2 more
openalex   +1 more source